Page last updated: 2024-10-24

camostat and Becker Muscular Dystrophy

camostat has been researched along with Becker Muscular Dystrophy in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Research Excerpts

ExcerptRelevanceReference
"Duchenne muscular dystrophy is known to be caused by a defective gene of dystrophin, a 427-kDa cytoskeletal protein, but the effective therapeutic drug is presently unavailable."1.32Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice. ( Ban, S; Kakefuda, R; Kikukawa, Y; Nagahiro, K; Sawada, H; Shiomi, T; Yokosawa, H, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawada, H1
Nagahiro, K1
Kikukawa, Y1
Ban, S1
Kakefuda, R1
Shiomi, T1
Yokosawa, H1

Other Studies

1 other study available for camostat and Becker Muscular Dystrophy

ArticleYear
Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:7

    Topics: Animals; Esters; Gabexate; Guanidines; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal;

2003